CNS Pharmaceuticals, Inc. · NASDAQ:CNSP
CNS Pharmaceuticals, Inc. shareholders
As of Sep 30, 2026, 12 institutions reported holding CNS Pharmaceuticals, Inc., 20.7% of its shares. Largest: Ikarian Capital, LLC, ADAR1 Capital Management, LLC and Stonepine Capital Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of CNS Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Ikarian Capital, LLC | 136K | 9.2% | no change | Nov 16, 2026 |
| ADAR1 Capital Management, LLC | 70,000 | 4.7% | no change | Nov 16, 2026 |
| Stonepine Capital Management, LLC | 39,942 | 2.7% | −1,631 | Nov 13, 2026 |
| Vanguard | 25,986 | 1.8% | +8,767 | Nov 13, 2026 |
| Citadel | 19,695 | 1.3% | new | Nov 16, 2026 |
| Boothbay Fund Management, LLC | 13,524 | 0.92% | no change | Nov 16, 2026 |
| Tower Research Capital LLC (TRC) | 150 | 0.01% | −649 | Nov 16, 2026 |
| UBS | 130 | <0.01% | −1,331 | Nov 10, 2026 |
| Fidelity | 26 | <0.01% | new | Nov 10, 2026 |
| Barrett & Company, Inc. | 8 | <0.01% | no change | Oct 22, 2026 |